Arsenene-mediated multiple independently targeted reactive oxygen species burst for cancer therapy

Na Kong(Brigham and Women's Hospital), Hanjie Zhang(Tianjin University), Chan Feng(Brigham and Women's Hospital), Chuang LIU(Brigham and Women's Hospital), Yufen Xiao(Brigham and Women's Hospital), Xingcai Zhang(Harvard University), Lin Mei(Chinese Academy of Medical Sciences & Peking Union Medical College), Jong Seung Kim(Korea University), Wei Tao(Brigham and Women's Hospital), Xiaoyuan Ji(Brigham and Women's Hospital)
Nature Communications
August 6, 2021
Cited by 216Open Access
Full Text

Abstract

Abstract The modulation of intracellular reactive oxygen species (ROS) levels is crucial for cellular homeostasis and determination of cellular fate. A sublethal level of ROS sustains cell proliferation, differentiation and promotes tumor metastasis, while a drastic ROS burst directly induces apoptosis. Herein, surface-oxidized arsenene nanosheets (As/As x O y NSs) with type II heterojunction are fabricated with efficient ·O 2 − and 1 O 2 production and glutathione consumption through prolonging the lifetime of photo-excited electron-hole pairs. Moreover, the portion of As x O y with oxygen vacancies not only catalyzes a Fenton-like reaction, generating ·OH and O 2 from H 2 O 2 , but also inactivates main anti-oxidants to cut off the “retreat routes” of ROS. After polydopamine (PDA) and cancer cell membrane (M) coating, the engineered As/As x O y @PDA@M NSs serve as an intelligent theranostic platform with active tumor targeting and long-term blood circulation. Given its narrow-band-gap-enabled in vivo fluorescence imaging properties, As/As x O y @PDA@M NSs could be applied as an imaging-guided non-invasive and real-time nanomedicine for cancer therapy.


Related Papers

No related papers found

Powered by citation graph analysis